Bio-Rad Laboratories Total Non-Operating Income/Expense 2010-2024 | BIO
Bio-Rad Laboratories annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- Bio-Rad Laboratories total non-operating income/expense for the quarter ending September 30, 2024 was $0.797B, a 1627.2% increase year-over-year.
- Bio-Rad Laboratories total non-operating income/expense for the twelve months ending September 30, 2024 was $-1.311B, a 139.11% increase year-over-year.
- Bio-Rad Laboratories annual total non-operating income/expense for 2023 was $-1.188B, a 77.1% decline from 2022.
- Bio-Rad Laboratories annual total non-operating income/expense for 2022 was $-5.187B, a 204.81% decline from 2021.
- Bio-Rad Laboratories annual total non-operating income/expense for 2021 was $4.949B, a 10.05% increase from 2020.
| Bio-Rad Laboratories Annual Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2023 | $-1,188 |
| 2022 | $-5,187 |
| 2021 | $4,949 |
| 2020 | $4,497 |
| 2019 | $2,031 |
| 2018 | $616 |
| 2017 | $-21 |
| 2016 | $-14 |
| 2015 | $-21 |
| 2014 | $-18 |
| 2013 | $-57 |
| 2012 | $-34 |
| 2011 | $-59 |
| 2010 | $-64 |
| 2009 | $-45 |
| Bio-Rad Laboratories Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2024-09-30 | $797 |
| 2024-06-30 | $-2,888 |
| 2024-03-31 | $446 |
| 2023-12-31 | $333 |
| 2023-09-30 | $46 |
| 2023-06-30 | $-1,590 |
| 2023-03-31 | $23 |
| 2022-12-31 | $973 |
| 2022-09-30 | $-302 |
| 2022-06-30 | $-1,343 |
| 2022-03-31 | $-4,514 |
| 2021-12-31 | $-2,145 |
| 2021-09-30 | $4,865 |
| 2021-06-30 | $1,032 |
| 2021-03-31 | $1,196 |
| 2020-12-31 | $903 |
| 2020-09-30 | $1,575 |
| 2020-06-30 | $1,194 |
| 2020-03-31 | $824 |
| 2019-12-31 | $640 |
| 2019-09-30 | $-393 |
| 2019-06-30 | $713 |
| 2019-03-31 | $1,071 |
| 2018-12-31 | $-814 |
| 2018-09-30 | $314 |
| 2018-06-30 | $296 |
| 2018-03-31 | $820 |
| 2017-12-31 | $-10 |
| 2017-09-30 | $-8 |
| 2017-06-30 | $3 |
| 2017-03-31 | $-6 |
| 2016-12-31 | $-8 |
| 2016-09-30 | $-5 |
| 2016-06-30 | $4 |
| 2016-03-31 | $-6 |
| 2015-12-31 | $-5 |
| 2015-09-30 | $-7 |
| 2015-06-30 | $-1 |
| 2015-03-31 | $-8 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-11 |
| 2014-06-30 | $3 |
| 2014-03-31 | $-6 |
| 2013-12-31 | $-8 |
| 2013-09-30 | $-34 |
| 2013-06-30 | $-4 |
| 2013-03-31 | $-11 |
| 2012-12-31 | $-8 |
| 2012-09-30 | $-11 |
| 2012-06-30 | $-7 |
| 2012-03-31 | $-8 |
| 2011-12-31 | $-12 |
| 2011-09-30 | $-18 |
| 2011-06-30 | $-10 |
| 2011-03-31 | $-19 |
| 2010-12-31 | $-21 |
| 2010-09-30 | $-17 |
| 2010-06-30 | $-13 |
| 2010-03-31 | $-13 |
| 2009-12-31 | $-14 |
| 2009-09-30 | $-16 |
| 2009-06-30 | $-7 |
| 2009-03-31 | $-8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $9.670B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.392B | 27.46 |
| Boston Scientific (BSX) | United States | $154.781B | 41.84 |
| Stryker (SYK) | United States | $150.988B | 32.49 |
| EssilorLuxottica (ESLOY) | France | $128.761B | 0.00 |
| Medtronic (MDT) | Ireland | $116.457B | 17.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.724B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.049B | 27.97 |
| Agilent Technologies (A) | United States | $42.120B | 27.91 |
| GE HealthCare Technologies (GEHC) | United States | $40.456B | 20.98 |
| ResMed (RMD) | United States | $34.834B | 26.83 |
| Terumo (TRUMY) | Japan | $27.701B | 39.39 |
| Koninklijke Philips (PHG) | Netherlands | $25.801B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.443B | 12.84 |
| Insulet (PODD) | United States | $20.179B | 80.36 |
| Baxter (BAX) | United States | $15.731B | 10.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.039B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.951B | 37.15 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.320B | 14.69 |
| Prestige Consumer Healthcare (PBH) | United States | $4.316B | 20.65 |
| ICU Medical (ICUI) | United States | $3.878B | 36.92 |
| Envista Holdings (NVST) | United States | $3.750B | 29.85 |
| Perrigo (PRGO) | Ireland | $3.407B | 10.03 |
| Haemonetics (HAE) | United States | $3.164B | 14.89 |
| GN Store Nord (GNNDY) | Denmark | $3.123B | 21.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.832B | 18.23 |
| Neogen (NEOG) | United States | $2.315B | 26.67 |
| LeMaitre Vascular (LMAT) | United States | $2.245B | 54.55 |
| AtriCure (ATRC) | United States | $1.997B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.513B | 26.48 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.29 |
| InMode (INMD) | Israel | $1.269B | 10.61 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.250B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.215B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.069B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 15.27 |
| Evolus (EOLS) | United States | $0.849B | 0.00 |
| CeriBell (CBLL) | United States | $0.810B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.21 |
| Capricor Therapeutics (CAPR) | United States | $0.652B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.627B | 27.14 |
| Valneva SE (VALN) | France | $0.563B | 0.00 |
| Omeros (OMER) | United States | $0.526B | 0.00 |
| SNDL (SNDL) | Canada | $0.507B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.474B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.424B | 0.00 |
| ZimVie (ZIMV) | United States | $0.383B | 32.26 |
| Canopy Growth (CGC) | Canada | $0.363B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 62.50 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Quanterix (QTRX) | United States | $0.320B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.292B | 19.55 |
| Biote (BTMD) | United States | $0.261B | 5.73 |
| Zynex (ZYXI) | United States | $0.252B | 52.80 |
| High Tide (HITI) | Canada | $0.238B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 3.26 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.226B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.203B | 15.16 |
| Brainsway (BWAY) | Israel | $0.200B | 106.40 |
| MacroGenics (MGNX) | United States | $0.174B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.83 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 11.44 |
| Exagen (XGN) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| InterCure (INCR) | Israel | $0.080B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| INLIF (INLF) | $0.067B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.064B | 33.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.051B | 14.60 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |